1. Home
  2. TRUP vs IVA Comparison

TRUP vs IVA Comparison

Compare TRUP & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trupanion Inc.

TRUP

Trupanion Inc.

HOLD

Current Price

$28.90

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$6.69

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRUP
IVA
Founded
2000
2011
Country
US
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
TRUP
IVA
Price
$28.90
$6.69
Analyst Decision
Buy
Strong Buy
Analyst Count
4
10
Target Price
$45.50
$16.20
AVG Volume (30 Days)
530.0K
518.7K
Earning Date
05-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
295.65
N/A
EPS
0.45
N/A
Revenue
$1,439,305,000.00
N/A
Revenue This Year
$12.42
N/A
Revenue Next Year
$9.39
N/A
P/E Ratio
$64.22
N/A
Revenue Growth
11.95
N/A
52 Week Low
$27.30
$2.70
52 Week High
$57.35
$7.98

Technical Indicators

Market Signals
Indicator
TRUP
IVA
Relative Strength Index (RSI) 33.08 63.61
Support Level $27.30 $5.95
Resistance Level $34.42 $6.37
Average True Range (ATR) 1.57 0.30
MACD -0.25 -0.03
Stochastic Oscillator 24.44 98.00

Price Performance

Historical Comparison
TRUP
IVA

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: